[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100605250":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":18,"locations":25,"responsibleParty":114,"collaborators":118,"id":122,"slug":18,"hasResults":123,"nctId":124,"briefTitle":125,"officialTitle":126,"acronym":127,"eligibilityCriteria":128,"healthyVolunteers":129,"sex":130,"minAge":131,"maxAge":18,"enrollmentInfo":132,"targetDuration":18,"studyType":135,"phases":136,"briefSummary":138,"conditions":139,"keywords":141,"overallStatus":66,"whyStopped":18,"lastUpdateSubmitDate":146,"lastUpdatePostDateStruct":147,"startDateStruct":150,"completionDateStruct":152,"leadSponsor":154,"locationsCount":155},{"fullName":5,"class":6},"University of Saskatchewan","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"PrEP Group","EXPERIMENTAL","Participants who have agreed to be on PrEP",[13],"Behavioral: Simultaneous administration of OAT and oral PrEP at existing pharmacy-based programs",{"label":15,"type":16,"description":17,"interventionNames":18},"Non-PrEP Group","NO_INTERVENTION","Participants who have declined PrEP",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","Simultaneous administration of OAT and oral PrEP at existing pharmacy-based programs","Simultaneous administration of OAT and oral PrEP (direct observed therapy or home supply) at existing pharmacy-based programs",[9],[26,47,64,83,94,104],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Sheldon M Chumir Health Centre","NOT_YET_RECRUITING","Calgary","Alberta","T2R 0X7","Canada",{"type":34,"coordinates":35},"Point",[36,37],-114.08529,51.05011,{"lat":37,"lon":36},[40,45],{"name":41,"role":42,"phone":43,"phoneExt":18,"email":44},"Caley Shukalek, MD, MPH","CONTACT","403-210-6093","cbshukal@ucalgary.ca",{"name":41,"role":46,"phone":18,"phoneExt":18,"email":18},"PRINCIPAL_INVESTIGATOR",{"facility":48,"status":28,"city":49,"state":50,"zip":51,"country":32,"cosmosGeoPoint":52,"geoPoint":56,"contacts":57},"Queen City Wellness Pharmacy","Regina","Saskatchewan","S4P 0H7",{"type":34,"coordinates":53},[54,55],-104.6178,50.45008,{"lat":55,"lon":54},[58,62],{"name":59,"role":42,"phone":60,"phoneExt":18,"email":61},"Sarah Kozusko, BScPharm","306-522-2266","skozusko@rubiconpharmacies.com",{"name":63,"role":46,"phone":18,"phoneExt":18,"email":18},"Cara Spence, PhD",{"facility":65,"status":66,"city":67,"state":50,"zip":68,"country":32,"cosmosGeoPoint":69,"geoPoint":73,"contacts":74},"Mayfair Drugs Pharmacy","RECRUITING","Saskatoon","S7L 0V8",{"type":34,"coordinates":70},[71,72],-106.66892,52.13238,{"lat":72,"lon":71},[75,79,82],{"name":76,"role":42,"phone":77,"phoneExt":18,"email":78},"Christine McDougall, RN","306-370-2320","mcdougall.christine@gmail.com",{"name":80,"role":42,"phone":18,"phoneExt":18,"email":81},"Chantelle Wong, BSc.","chw454@usask.ca",{"name":63,"role":46,"phone":18,"phoneExt":18,"email":18},{"facility":84,"status":66,"city":67,"state":50,"zip":85,"country":32,"cosmosGeoPoint":86,"geoPoint":88,"contacts":89},"Pharmasave Riversdale Pharmacy","S7M 0Y2",{"type":34,"coordinates":87},[71,72],{"lat":72,"lon":71},[90,92,93],{"name":76,"role":42,"phone":91,"phoneExt":18,"email":78},"1-306-370-2320",{"name":80,"role":42,"phone":18,"phoneExt":18,"email":81},{"name":63,"role":46,"phone":18,"phoneExt":18,"email":18},{"facility":95,"status":66,"city":67,"state":50,"zip":96,"country":32,"cosmosGeoPoint":97,"geoPoint":99,"contacts":100},"The Medicine Shoppe Pharmacy","S7M 0Z7",{"type":34,"coordinates":98},[71,72],{"lat":72,"lon":71},[101,102,103],{"name":76,"role":42,"phone":77,"phoneExt":18,"email":78},{"name":80,"role":42,"phone":18,"phoneExt":18,"email":81},{"name":63,"role":46,"phone":18,"phoneExt":18,"email":18},{"facility":105,"status":66,"city":67,"state":50,"zip":106,"country":32,"cosmosGeoPoint":107,"geoPoint":109,"contacts":110},"Meadowgreen Pharmacy","S7M 4R5",{"type":34,"coordinates":108},[71,72],{"lat":72,"lon":71},[111,112,113],{"name":76,"role":42,"phone":77,"phoneExt":18,"email":78},{"name":80,"role":42,"phone":18,"phoneExt":18,"email":81},{"name":63,"role":46,"phone":18,"phoneExt":18,"email":18},{"type":115,"investigatorFullName":116,"investigatorTitle":117,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"SPONSOR_INVESTIGATOR","Cara Spence","Lead Principal Investigator in Saskatchewan, Canada",[119],{"name":120,"class":121},"Gilead Sciences","INDUSTRY","100605250",false,"NCT07160075","HIV Prevention With PrEP Among People on Opioid Replacement Therapy","Improving Access to HIV Pre-exposure Prophylaxis: Implementation and Evaluation of Innovative HIV Prevention Services Among Persons on Opioid Replacement Therapy in Western Canada: Prospective, Implementation Study","OAT-PrEP","Inclusion Criteria:\n\n* HIV negative\n* Ongoing behaviors with potential HIV exposure as assessed by a clinician\n* Regularly engaged with their respective OAT program at least 3 days a week for the past 2 weeks\n* Report willingness to return for follow-up visits\n\nExclusion Criteria:\n\n* Creatine clearance \\\u003C30 mL\u002Fmin or any medical condition or medication known to be contraindicated with the use of Emtricitabine\u002FTenofovir Alafenamide (F\u002FTAF) or Emtricitabine\u002FTenofovir Disoproxil Fumarate (F\u002FTDF)\n* Taken PrEP within the last 24 hours at the time of screening or enrollment\n* Deemed appropriate by a clinician for HIV Post-Exposure Prophylaxis at the time of screening or enrollment",true,"ALL","16 Years",{"count":133,"type":134},350,"ESTIMATED","INTERVENTIONAL",[137],"PHASE4","The purpose of this study is to assess the feasibility and acceptability of providing oral pre-exposure prophylaxis (PrEP) and opioid agonist therapy (OAT) simultaneously in existing pharmacy-based programs operating in Alberta and Saskatchewan, to collect preference, adherence, and persistence data on oral PrEP, and to assess interest \u002F acceptability of long-lasting injectable options for human immunodeficiency virus (HIV) prevention.",[140],"HIV - Human Immunodeficiency Virus",[142,143,144,145],"PrEP","OAT","Opioid Agonist Therapy","HIV","2025-10-01",{"date":148,"type":149},"2025-10-07","ACTUAL",{"date":151,"type":149},"2025-08-28",{"date":153,"type":134},"2027-09-01",{"name":116,"class":6},6]